Buchumschlag

Machine Learning Algorithms for Predicting Injurious Fall Risk Among Older Adults With Depression: A Prognostic Modeling Study

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Grace Hsin‐Min Wang, Yao‐An Lee, Amie J. Goodin, Rachel C. Reise, Ronald I. Shorr, Wei‐Hsuan Lo‐Ciganic
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Hyperfiltration in Critically Ill Older Adults: Incidence, Risk Factors, Time Course, and Predictive Performance of Kidney Function Estimation
von: Ryusei Mikami, et al.
Veröffentlicht: (2026)

Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or Remitted Depression”
Veröffentlicht: (2025)

Predictors and Clinical Outcomes of Long‐Term Opioid Therapy in Older Adults: A Systematic Review
von: Iftekhar Ahmed, et al.
Veröffentlicht: (2026)

Utilizing Machine Learning to Identify Predictors of Corticosteroid Discontinuation 1‐Year After Adult Heart Transplant
von: Caroline Chen, et al.
Veröffentlicht: (2025)

Lithium Augmentation in Treatment‐Resistant Depression: A Qualitative Review of the Literature
von: Angela Acero‐González, et al.
Veröffentlicht: (2025)

Thromboembolic Risk of Thrombopoietin Receptor Agonists for Adult Primary Immune Thrombocytopenia: A Systematic Review and Meta‐Analysis Integrating Randomized Controlled Trials and Prospective Evidence
von: Meng‐Fei Dai, et al.
Veröffentlicht: (2025)

Association of Serotonin Transporter Gene 5HTTLPR rs25531 Polymorphism With Escitalopram Efficacy in Patients With Major Depressive Disorder
von: Muhammad Faisal Afridi, et al.
Veröffentlicht: (2026)

External Validation of the Fraser Equation for Estimation of Free Valproate Concentrations in Critically Ill Adults
von: Andrew J. Webb, et al.
Veröffentlicht: (2025)

Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta‐Analysis
von: Daniela Gorski, et al.
Veröffentlicht: (2025)

Cost‐Effectiveness Analysis of Patient Self‐Management of Warfarin Among Patients With Non‐Valvular Atrial Fibrillation
von: Warittakorn Kategeaw, et al.
Veröffentlicht: (2026)

High‐Throughput Screening for Prescribing Cascades Among Real‐World Angiotensin‐ II Receptor Blockers ( ARBs ) Initiators
von: Asinamai M. Ndai, et al.
Veröffentlicht: (2025)

Pharmaceutical Considerations for Oncology Risk, Screening, and Drug Dosing in the Transgender Population
von: Amy Broadwater, et al.
Veröffentlicht: (2026)

Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on Proteinuria in Kidney Transplant Recipients
von: Stephanie Shabanowitz, et al.
Veröffentlicht: (2026)

Updates in chronic kidney disease management: A systematic review
von: Amina Ammar, et al.
Veröffentlicht: (2025)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
von: Maryam Aghakouchakzadeh, et al.
Veröffentlicht: (2026)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
von: Keith A. Rodvold
Veröffentlicht: (2026)

Machine Learning‐Based Prediction of Prolonged Duration of Mechanical Ventilation Using Medication Data
von: Brian Murray, et al.
Veröffentlicht: (2026)

Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis
von: Wenqiang Zhou, et al.
Veröffentlicht: (2026)

Development and Validation of a Novel Scoring Model Integrating Clinical Risk Factors and Pharmacokinetic Parameters to Predict Vancomycin‐Induced Nephrotoxicity
von: Yoshihiko Matsuki, et al.
Veröffentlicht: (2026)

Risk of acute kidney injury in dapagliflozin users with type 2 diabetes: A nationwide propensity score‐matched cohort study in Korea
von: Hee‐Jin Kim, et al.
Veröffentlicht: (2025)

Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Partial‐ and Full‐Thickness Skin Burns
von: Ronald G. Hall, et al.
Veröffentlicht: (2025)

Retrospective cohort study of oral switch versus intravenous antibiotics for carbapenem‐resistant enterobacterales and Pseudomonas aeruginosa infections on hospital discharge
von: Christen J. Arena, et al.
Veröffentlicht: (2025)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
von: Amanda Massmann, et al.
Veröffentlicht: (2025)

Correction to “Risk of incident antidepressant‐treated depression associated with use of 5α‐reductase inhibitors compared with use of α‐blockers in men with benign prostatic hyperplasia: A population‐based study using the Clinical Practice Research Datalink”
Veröffentlicht: (2024)

Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia
von: Rachel D. Harris, et al.
Veröffentlicht: (2024)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
von: Alexandre Duong, et al.
Veröffentlicht: (2024)

Cancer Treatment Modalities and Female Fertility Preservation
von: Seonga Song, et al.
Veröffentlicht: (2026)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
von: Mohammed Al Musawa, et al.
Veröffentlicht: (2024)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
von: Atif Siddiqui
Veröffentlicht: (2025)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
von: Jiwon Kim, et al.
Veröffentlicht: (2025)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
von: Hua‐Ping Fan, et al.
Veröffentlicht: (2024)

Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
von: Nicolette Centanni, et al.
Veröffentlicht: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
von: Yi‐Fan Chien, et al.
Veröffentlicht: (2025)

In Search of Big Beautiful Biomarkers
von: C. Lindsay DeVane
Veröffentlicht: (2025)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
von: Carlos Augusto Espinoza Cobeñas
Veröffentlicht: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
von: Lisa T. Hong, et al.
Veröffentlicht: (2024)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
von: Nihal El Rouby, et al.
Veröffentlicht: (2025)

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
von: Trisha Matsuura, et al.
Veröffentlicht: (2025)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
von: Amira R. Rashdan, et al.
Veröffentlicht: (2026)

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
von: Kathleen A. Stringer, et al.
Veröffentlicht: (2025)